Outset Medical shares took a hit after the at-home dialysis tech company announced a shipment hold within its second-quarter results. Shares of OM fell 12.7% at $16.91 apiece in after-hours trading after the release of the news yesterday evening. By midday today, OM shares had recovered slightly, down more than 10% to $17.27 apiece MassDevice‘s […]
Dialysis
Fresenius Medical Care stock dips on mixed Q2 results
Fresenius Medical Care shares fell this morning on second-quarter results that came in mixed compared to the consensus forecast. Shares of FMS were down 2% at $25.33 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell by nearly 1%. The Germany-based dialysis […]
Baxter names proposed kidney care spinoff ‘Vantive’
Baxter announced today that it picked “Vantive” as the name of its proposed kidney care spinoff. In January, Baxter announced plans to spin its renal care and acute therapies units into an independent, publicly traded company. It said at the time that it expected the company to stand alone in the next 12 to 18 […]
Fresenius Medical Care converts to German stock corporation to simplify corporate structure
Fresenius Medical Care announced today that an Extraordinary General Meeting (EGM) saw shareholders approve a change to corporate structure. The renal disease treatment product provider’s shareholders approved all EGM agenda meetings with a large majority. One major approval was the conversion of Fresenius Medical Care from the legal from of a partnership limited by shares […]
Fresenius Medical Care appoints new CFO
Fresenius Medical Care announced today that it appointed Martin Fischer as its new chief financial officer (CFO). Fischer’s appointment goes into effect on Oct. 1, 2023. He succeeds Helen Giza, who took over as CEO and board chair in December 2022. She took on the corner office after CEO Carla Kriwet decided to leave the […]
Outset Medical stock sinks after it receives FDA warning letter
Outset Medical announced that it received a warning letter from the FDA related to its Tablo system. San Jose, California-based Outset previously disclosed an FDA Form 483 in its annual report in February. That FDA form identified four inspectional observations resulting from an inspection concluded on Feb. 10, 2023. From there, Outset provided a response […]
Merit Medical spends $132.5M on acquisitions to expand its offerings
AngioDynamics (Nasdaq:ANGO) announced that it completed the sale of its dialysis product portfolio to Merit Medical Systems. It was part of a series of product acquisitions worth $132.5 million that Merit (Nasdaq: MMSI) has announced. Latham, New York-based AngioDynamics sold its dialysis portfolio and the BioSentry product for $100 million in cash. The transaction includes […]
Outset Medical upgrades full-year guidance after strong Q1 performance
Outset Medical this week posted first-quarter results that beat the overall consensus on Wall Street. The San Jose, California-based dialysis company reported profit losses of $43.97 million, or 90¢ per share, on sales of $33.5 million, for the three months ended March 31, for a sales gain of 9.55% compared to Q1 2022. It had […]
Medtronic, DaVita launch Mozarc kidney care spinoff
Medtronic and DaVita (NYSE:DVA) announced the official launch of their kidney care spinoff, called Mozarc Medical. In May 2022, the two companies announced their intent to form a new medical device company for kidney care. They temporarily dubbed the company “NewCo.” Medtronic and DaVita described its mission as aiming to enhance the patient experience and improve outcomes […]
Medtronic and DaVita’s dialysis venture appears to be called Mozarc Medical
Regulatory filings indicate a medtech CEO is involved in the new kidney care company.
Clues are pointing to Mozarc Medical as the name of the new kidney care company that Medtronic (NYSE:MDT) and DaVita (NYSE:DVA) are expected to launch this year. The companies used “NewCo” as a placeholder when announcing the new company last year and said a renaming and rebranding would come when the deal closes sometime in […]
Outset Medical beats The Street in Q4, reaffirms guidance
At-home hemodialysis technology developer Outset Medical (Nasdaq:OM) reported fourth-quarter results that topped the consensus forecast. Shares of OM, however, took a hit the morning following the company’s earnings call after the market closed yesterday. They dropped more than 12% to $25.02 apiece by midday. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest […]